EMA safety committee to review link between semaglutide and rare eye condition The review will include data from clinical trials, post-marketing surveillance, studies on the mechanism of action and medical literature.…
Weight-loss drug use linked to reduced risk of substance misuse, study shows Results of the cohort analysis suggest that glucagon-like peptide-1 receptor agonists cut the risk of use of substances including alcohol, cannabis and opioids.…
Optimising use of SGLT2 inhibitors in hospital patients How pharmacists can evaluate SGLT2 inhibitor use in hospitalised patients with a well-balanced approach so that patients can simultaneously benefit from SGLT2 inhibitors and the reduction of diabetic ketoacidosis risk.…
British public divided on whether NHS should offer weight-loss jabs, survey results show The findings of the Ipsos 'Public attitudes toward weight-loss injections' poll show that 37% of British adults surveyed support weight-loss injections being offered on the NHS, while 32% said they were opposed.…
Generic weight loss drugs could alleviate shortages, says BGMA Although the British Generic Manufacturers Association anticipates at least four companies receiving UK marketing authorisations for type 2 diabetes and obesity, it remains unclear how many will be rolled out immediately.…
Manufacturer confirms discontinuation of type 2 diabetes mellitus treatment Victoza Victoza (liraglutide) 6mg/mL pre-filled injection pens have been out of stock in the UK since August 2023.…
Problems with diabetes monitoring devices are potentially being underreported, says MHRA The regulator has urged people to speak to a healthcare professional if they have concerns that their health may have been impacted by an issue with their device.…
Pharmacy-led national diabetes screening service could save NHS £50m a year, says CCA The Company Chemists’ Association said pharmacies across England could screen up to 1.5 million adults annually.…
Weekly insulin injection as effective as daily injections in type 1 and type 2 diabetes, research suggests Two studies have suggested that a once-weekly injection of insulin has a similar effectiveness for blood sugar management as daily injections.…
MHRA finds no link between GLP-1 receptor agonists and suicidal behaviour The regulator says it will continue to monitor the risk of severe psychiatric reactions and assess new data as they become available.…
